Contact lenses (CLs) offer a wide variety of advantages as ocular drug-releasing platforms,
but the feasibility of medicated CL development is constrained by numerous scientific …

For the treatment and prevention of ocular diseases, most patients are treated with
conventional drug delivery formulations such as eye drops or ointments. However, eye …

Introduction: Ocular drug delivery is a very challenging endeavor due to the unique
anatomical and physiological barriers. The low ocular bioavailability (< 10%) obtained from …

Intravitreal implantable device technology utilizes engineered materials or devices that
could revolutionize the treatment of posterior segment eye diseases by affording localized …

Abstract The European Paediatric Formulation Initiative (EuPFI), a group consisting of
paediatric formulation experts from industry, academia and clinical pharmacy was founded …

The complexity of the structure and nature of the eye emanates a challenge for drug delivery
to formulation scientists. Lower bioavailability concern of conventional ocular formulation …

Central venous catheters (CVCs) have become indispensable in the treatment of neonates
and patients undergoing chemotherapy or hemodialysis. A CVC provides easy access to the …

Eye drops have long been the primary ocular drug delivery dosage form used to treat ocular
disorders ranging from superficial conditions to intravitreal diseases. The ocular anatomical …

Vision significantly affects quality of life and the treatment of ocular disease poses a number
of unique challenges. This review presents the major challenges faced during topical ocular …

For the treatment of anterior eye segment infections using anti-infective agents, topical
ocular application is the most convenient route of administration. However, topical delivery …